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A New Interdisciplinary Field In Bioelectrics 
Bioelectrics is a burgeoning new interdisciplinary field, unifying 
an interdisciplinary team of scientists who integrate knowledge of 
electrical principles and theory, modeling and simulations, physics, 
material sciences, molecular cell biology, animal sciences and medicine. 
It investigates interactions of electric fields with cells and tissues for 
a number of possible basic science and therapeutic applications. 
There are also possible environmental applications. Bioelectrics was 
initially realized, but not specifically defined or named, when it was 
found that microsecond electric field effects on plasma membranes 
enhanced the penetration of DNA into mouse L-cells developing 
stable transformants [1]. This electric field mediated DNA transfer 
was called electroporation, and a model was proposed that electric 
field interactions with lipid dipoles in a pore configuration enhanced 
transport across the plasma membrane. More recently, pulse power 
technology, which originally was used for military purposes, has been 
applied to cells and tissues. This has led to some new and innovative 
possibilities for a number of potential uses. Of specific interest is to 
determine the nature of electric field interactions with cell membranes 
and other cellular structures, to determine how these effects alter cell 
functions, and to determine how Bioelectrics can be applied for basic 
science and medical advantages. 
Applications of bioelectrics 
Ageneral overview of uses for Bioelectrics includes applications 
that deliver DNA to cells and tissues, transiently or permanently alter 
cell membranes and other cell constituents, modulate cell signaling 
mechanisms, disinfect and decontaminate. Therapeutic applications 
include treating cancer [2-7], coronary and peripheral vascular disease 
[8]; activating platelets to enhance wound healing [9]; modulating 
cardiomyocyte action potentials [10]; transfecting plasmids for protein 
expression to improve wound healing [11], and to enhance immune 
responses [12]; vaccinating against diseases [13]; possibly imaging 
malignancies [14], and controlling pain by blocking nerve conduction 
[15]. Other applications include using electric fields [16,17] and cold 
plasmas [18], for sterilizing liquids, foods and surfaces; purifying air 
and water [19], and removing oxides of nitrogen and sulfur from diesel 
exhaust [20]. Another new field emerging in Bioelectrics is plasma 
medicine, where room temperature atmospheric pressure plasmas are 
used for sterilization, hygiene and dental/medical applications [21]. 
In this review, a major focus will be on applying milli-, micro- 
and nano-second pulsed electric fields (nsPEFs) in basic science and 
medicine. Most space will be filled on efficacy and mechanisms of 
cancer ablation with nsPEFs, in vitro and in vivo. For topics of materials 
sciences and engineering, the emphasis is to analyze interactions 
of electric field waveforms with biological materials, including cell 
membranes and other cellular components for medical applications. 
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Abstract
Bioelectrics is a new interdisciplinary field that investigates electric field effects on cell membranes and other 
cellular components. It incorporates four main technologies, including electroporation, nanosecond pulsed electric 
fields, picosecond pulsed electric fields and cold plasmas. The parent technology in Bioelectrics is electroporation, 
which uses milli- and/or micro-second electric pulses to permeabilize cells and tissues, for delivery of membrane 
impermeable molecules. It is now being used for electro-gene delivery, with vascular endothelial growth factor, for 
revascularization in wound healing and cardiovascular and peripheral vascular disease. Plasmids expressing IL-12 are 
being delivered for immune system activation in melanoma treatment, now in phase II clinical trials. DNA vaccine delivery 
by electroporation is also being investigated. More recently, electroporation has been extended to include nanosecond 
pulsed electric fields (nsPEFs), a pulse power technology that was originally designed for military applications. It stores 
intense levels of electric energy, and then unleashes nanosecond bursts of instantaneous power into cells and tissues, 
creating unique intracellular conditions of high power and low, non-thermal energy. It is presently being used for cancer 
ablation of skin and internal tumors, and for platelet activation for wound healing in injury and diabetes. An extension 
of nsPEFs is to make the pulses even shorter, using picosecond pulsed electric fields. This is being developed as an 
imaging system to detect cancer and other aberrant tissues, using an antenna. The fourth technology is cold plasmas 
or ionized gasses, a fourth state of matter. Applications of these ionized gases are being developed for decontaminating 
wounds, water, food and surfaces. Other possible applications that are of specific interest, but not yet fully investigated, 
and/or developed, are pain control, fat ablation and decontamination of indwelling catheters. This review will outline 
some applications of Bioelectrics, with greatest focus on nsPEF effects on cells in vitro and tumors in vivo. 
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Electroporation for Drug and Gene Delivery 
As indicated above, the most notable and recognized application 
of Bioelectrics is the use of external electric fields on biological cells 
to permeabilize cell membranes by electroporation [1]. In practice, 
electroporation is used to deliver impermeable molecules, such 
as nucleic acids, drugs or other molecules obstructed by plasma 
membranes. With potential problems for DNA delivery by viruses, 
delivery of plasmids or other nucleic acids to cells and tissues by 
electroporation has been shown to be safe and effective in humans 
[12]. It was also shown that only minor histological changes occurred 
in electroporated muscle [22], with neither little or no changes in gene 
profiles for major tumor suppressor genes or oncogenes of the cell 
cycle, nor change in expression of genes involved in DNA stability [23]. 
One practical medical application for electroporation is to permeabilize 
tumor cell membranes for the delivery of poorly permeable drugs, 
such as bleomycin, in a procedure called electrochemotherapy (ECT). 
Although not generally used in the US, ECT is now widely and 
successfully used in Europe for the treatment of cancer [24]
Electrogene therapy for cancer treatment
Use of the C57Bl/6 mouse harboring B16F10 melanoma tumors 
demonstrated feasibility for therapeutic applications of electro-gene 
therapy (EGT) to treat tumors. Initial thoughts were to use EGT for 
replacing defective genes. However, a major focus has been on several 
basic strategies for cancer therapy, including immune potentiation, 
suicide gene therapy, restoration of tumor suppressor genes, 
inhibition of oncogenes, anti-angiogenic gene therapy, delivering 
genes encoding toxins, or siRNAs to knockdown proteins important 
for survival and growth [25-27]. The delivery of a plasmid for IL-12 
to metastatic melanoma tumors showed safety, efficacy reproducibility 
and titratability in Phase I clinical trials [12]. 42% of melanoma 
patients who had no other approved treatment options showed disease 
stabilization or partial responses. In addition, 2 of 19 patients with 
non-electroporated distant lesions and no other systemic therapy 
showed complete regression of all metastases. Phase II clinical trials are 
ongoing. In pre-clinical trials [28], EGT utilizing a plasmid encoding 
for vascular endothelial growth factor (VEGF) demonstrated that 
wound healing could be accelerated [11]. Other studies found that high 
antibody titers after electroporation delivery of a plasmid encoding 
Hepatitis B surface antigen could be achieved after two applications 
[13]. 
Electrogene therapy for cardiovascular disease
EGT has also been shown to be effective in vivo to ischemic swine 
hearts, as a potential therapeutic approach for treatment of heart 
diseases [8]. Using three different penetrating electrodes and one 
non-penetrating electrode, the authors have shown that gene transfer 
to ischemic hearts via electroporation can be a safe and effective, 
non-viral method for delivering genes in vivo. Eight electric pulses 
of various widths and field strengths were synchronized to the rising 
phase of R waves of electrocardiograms, following an injection of 
either a plasmid encoding luciferase, or one encoding green fluorescent 
protein. Four different sites on the anterior wall of the left ventricle 
were treated. Expression was significantly higher in all electroporated 
sites, when compared to sites with plasmid injection only. It will now 
be interesting to determine if therapeutic genes such as VEGF can be 
effectively delivered to hearts after myocardial infarction, and if the 
expressed gene can improve cardiac function following an ischemic 
event. 
Cell survival and DNA delivery during electroporation of course 
EGT requires that cells survive electroporation treatment, so they can 
express the gene of interest. Thus, there is a threshold transmembrane 
voltage that establishes permeabilization, another threshold that 
optiwmizes gene delivery and minimizes cell death; however, this 
condition may or may not be the condition that optimizes gene 
expression. Finally, there is a threshold that completely compromises 
cell viability, such that cells are irreversibly permeabilized [1,29-31]. 
Using this technique of Irreversible Electroporation (IRE) [32], is now 
in clinical trials for liver cancer treatment. 
Exactly how electric fields affect cell membranes and other 
cellular mechanisms is still not completely understood. The term 
electroporation implies that “pores” or “aqueous channels” are formed 
in plasma membranes. This is consistent with transport of ions across 
membranes, as determined by a number of methods, including 
molecular dynamic simulations [33,34] and patch clamp studies [35], 
among others. However, it is unlikely that DNA diffuses into cells 
through these so-called pores. There is general agreement that the 
primary role in pore formation is played by water dipoles as they create 
water defects, and as they increasingly interact with electric fields at the 
lipid-water interface; initial steps in pore formation do not depend on 
the nature of lipid headgroups [33,34]. A number of steps are required 
for DNA entry into cells: electrophoretic migration of DNA towards 
the cell, DNA insertion into the membrane, translocation across 
the membrane, migration of DNA towards the nucleus, and finally 
transfer of DNA across the nuclear envelope [29,35-37]. Continuing 
investigations now suggest that these electric fields affect endocytotic 
mechanisms, engulfing DNA in membrane bound vesicles [38-40]. 
While this may account for how DNA gets into cells, it remains to 
be determined how DNA is released from these vesicles, enters the 
nucleus, and is engaged for gene transcription. 
Pulse Power Technology And Nanosecond Pulsed 
Electric Fields (nsPEFs) 
Comprehending pulse power
All electric methods discussed above use millisecond or microsecond 
pulses and relatively low electric fields. For ECT and EGT, electric field 
strengths are in the range of V/cm; however, IRE electric fields are 
generally in the low kV/cm range. A more recent approach is to make 
greater use of pulse power technology by shortening pulse durations 
into the nanosecond domain, and increasing electric field strengths 
into the range of tens or hundreds of kV/cm [41-43]. By storing electric 
energy in capacitors and releasing it in sub-microsecond bursts, electric 
fields can be delivered to cells and tissues with unique qualities of high 
peak power and low energy. When pulse repetition rates are relatively 
low, effects are non-thermal. The power is high because it is released 
in nanosecond durations. An example of pulse power principles is to 
compare storage of one joule of energy released in one second versus 
releasing the same energy in one microsecond or one nanosecond. If 
the stored joule of energy is released all at once in one second, the peak 
power delivered would only be 1 watt. If all of the stored energy were 
released within one microsecond, the power would be one megawatt, 
a million times greater; if released in one nanosecond, the peak power 
would be one gigawatt, a billion times greater. This is enough power to 
light a medium sized city for that nanosecond. 
Perceiving the nanosecond time domain
To conceptualize nanoseconds, consider that the blink of an eye 
takes about 0.2 seconds or 200 milliseconds (ms). So, 60 ms would be 
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about one quarter of the blink of an eye, or a very quick blink. Then, 
60 nanoseconds would be 1/4000 of the blink of an eye. Another 
comparison is to consider the distance that light travels in a given 
amount of time. Light travels 300 million meters/sec, or about 0.3 
meters/ns, or about 1 foot. For pulse durations used in studies discussed 
here, often 60-100 ns, light would travel about 20-30 yards; the distance 
for 2 or 3 first downs on a football field. Of specific interests here are the 
consequences of these nanosecond bursts, and the interactions of these 
intense electric fields with cell and tissue structures, and ultimately, 
with cell and tissue functions. 
Intracellular effects and nanoporation with nsPEFs
Unlike conventional electroporation pulses, nanosecond pulses 
are hypothesized to affect intracellular membranes. Therefore, a 
major focus has been on nsPEF effects on the endoplasmic reticulum, 
other calcium stores, mitochondria, and/or nuclei. The premise states 
that pulses with short durations and rapid (short) pulse rise and fall 
times charge intracellular membranes, which would have different 
effects on cell structures, and functions compared to conventional 
electroporation. When considering this pulse rise-fall principle in the 
frequency domain instead of the time domain, these rise-fall times 
would exhibit transient high frequency components, which affect 
intracellular membranes [44,45]. The initial concept of nsPEF effects 
was that plasma membranes were not affected or less affected. In 
experiments with cells in vitro, calcein did not escape from intracellular 
vesicles into the cytoplasm [41], and propidium iodide (PI) did not 
initially enter cells [42,46], suggesting that plasma membranes remained 
intact. Later it became clear that breaches in plasma membranes were 
too small to allow escape or admission of molecules with sizes larger 
than about a nanometer, slighter smaller than calcein and PI. Modeling 
results showed nsPEF-induced conditions of supra-electroporation or 
formation of high density nanopores in all cell membranes [47,48], 
which were later demonstrated experimentally. Experimental results 
demonstrated that cell membranes were depolarized and ions smaller 
than calcein and PI, such as TI [49] and Ca2+ [45] crossed plasma 
membranes under certain conditions, without transport of these 
larger molecules. Plasma membranes were depolarized and membrane 
potentials approached zero after cells were exposed to nsPEFs [50]. 
When nsPEFs were shown to eliminate cancer cells, evidence was 
interpreted as markers for apoptosis [2,51,52] and necrosis [50]. Such 
mechanisms could generally result from effects on plasma membranes, 
intracellular membranes, or both. 
In Vitro Evidence For Cell Death Mechanisms In 
Response To nsPEFs 
Extrinsic or intrinsic cell death?
It was hypothesized that nsPEF-induced apoptosis resulted from 
supra-electroporation [48]. Again, this could be due to extrinsic effects 
on plasma membranes, or intrinsic effects on endoplasmic reticulum, 
mitochondria and/or nuclei/DNA. Lysosomes could also be affecting, 
but have not been analyzed. In vitro studies in B16f10 melanoma [53] 
and E4 squamous cell carcinoma (SCC) [54] suggested that extrinsic 
apoptosis was at least partly involved, and caspase-independent cell 
death mechanisms were also implicated. For activation of an extrinsic 
pathway, it was possible that nsPEF effects on plasma membranes 
would aggregate Fas receptors. This would induce formation of the 
death-induced signaling complex (DISC), which is composed of Fas 
associated death domain (FADD), and inactive caspase-8 binding 
to the intracellular domains of the Fas receptor. By this mechanism, 
caspase-8 would be activated. Caspase-8 could then directly activate 
caspase-3 (type I cells) or cleave Bid (type II cells), which would lead 
to cytochrome c release, activation of caspase-9, and then, activation 
of caspase-3. 
Extrinsic cell death?
To test for extrinsic apoptotic cell death, wild type Jurkat clones 
were compared to clones deficient in FADD (ΔFADD) or caspase-8 
(Δcaspase-8) [55]. Caspase activities [-8,-9,-3] were increased in 
electric field- and time-dependent manners in all clones. When these 
clones were treated with ten 60 ns pulses with increasing electric fields 
(0-60 kV/cm), there were no differences in electric field effects on cell 
viability. All of these clones had electric field LD 50 values of about 
30 kV/cm. However, it has been shown that nearly all cell types will 
die when given lethal apoptotic stimuli, in the presence of caspase 
inhibition with the pan caspase inhibitor z-VAD-fmk [56,57]. Thus, in 
ΔFADD and Δcaspase-8 caspase experiments, this did not really rule 
out an extrinsic apoptosis pathway in nsPEF treated cells. However, 
it did show that like other apoptosis stimuli, nsPEFs activate similar 
caspase-independent cell death mechanisms in the absence of caspase 
activities. 
To more specifically test for nsPEF-activated extrinsic apoptosis, 
cells were analyzed for cytochrome c release in the presence of the pan 
caspase inhibitor z-VAD-fmk. Under these conditions, if the extrinsic 
pathway were activated, cytochrome c release would be decreased in 
nsPEF-stimulated cells. However, results revealed that cytochrome c 
release was not affected by lethal nsPEF conditions at times up to 6 
hours after treatment [55]. This indicated that the extrinsic pathway, 
and/or other pathways that may require FADD or caspase-8 were not 
functional in Jurkat cells, in response to nsPEFs. 
Intrinsic cell death
Having ruled out the extrinsic pathway, the intrinsic pathway was 
tested using a Jurkat clone deficient in APAF-1 (ΔAPAF-1) [55]. APAF-
1 is required in the intrinsic pathway to form the apoptosome, including 
a complex of APAF-1 with cytochrome c, d-ATP and caspase-9, 
which activates caspase-9. Caspase-9, then, activates caspase-3. It was 
shown that nsPEFs did not activate caspase-3 in ΔAPAF-1, but did 
in the vector control and wild type clone [55]. When analyzing cell 
viability, the vector control exhibited a linear electric-field dependent 
decrease in viability for 0-60 kV/cm, with significant decreases in cell 
viability at 20 kV/cm. In contrast, ΔAPAF-1 did not show significant 
decreases in cell viability, until about 40 kV/cm. Between 50 and 60 kV/
cm, there were no differences in cell viability between the two clones. 
These results demonstrated for the first time that nsPEF-induced cell 
death was APAF-1- and caspase-dependent at lower electric fields, 
but caspase-independent at higher electric fields. Thus, in Jurkat 
cells, nsPEF-induced cell death occurred through intrinsic pathways 
in the functional absence of extrinsic apoptosis involving FADD and 
caspase-8. 
NsPEF subcellular targets for cell death induction
Although type I and type II extrinsic pathways were not operative 
in response to nsPEFs, roles for plasma membranes, intracellular 
membranes, mitochondria and DNA/nuclei in cell death had not 
been fully investigated. Release of calcium from the endoplasmic 
reticulum (ER) previously had been shown as an intracellular effect 
of nsPEFs [42,58]. In addition, nsPEFs were shown to dissipate the 
mitochondria membrane potential (ΔΨm) [53,54,59,60]. To carry 
these analyses further, it was of interest to determine how increases 
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in intracellular calcium and loss of ΔΨm were involved in cell death. 
N1-S1 hepatocellular carcinoma (HCC) cells we used [44,45], which 
are used in an in vivo orthotopic HCC model in rats. Calcium release 
from intracellular stores was not observed in N1-S1 cells, using Fluo-
4 as the calcium indicator. Since release of calcium from the ER 
had been shown before [42,58], this suggested that calcium was not 
released from intracellular stores in N1-S1 HCC cells, that Fluo-4 was 
not sufficiently sensitive to detect it, or that increases in calcium were 
transient and absent when they were analyzed in these studies 10-30 
minutes after treatment. However, nsPEF-induced influx of calcium 
through plasma membranes was readily evident, as was dissipation of 
(ΔΨm). To determine roles for intracellular calcium and ΔΨm on cell 
viability, the theory was directly tested that high frequency components 
of nsPEFs (transient pulse features), which are determined by rapid 
(short) rise and fall times of pulses, are important for maximizing 
electric field interactions with intracellular membranes [44,45]. Here, 
the intracellular effect was dissipation of ΔΨm. Using one 600 ns 
pulse with fast (15 ns) and slow (150 ns) rise-fall times and increasing 
electric fields, pulses with short rise-fall times had greater effects on 
dissipation of ΔΨm, confirming the theory that transient pulse features 
of nsPEFs were an important component for intracellular effects. In 
addition, decreases in viability were parallel with dissipation of ΔΨm. 
Moreover, under conditions of a slow rise-fall time and a mismatched 
load, influx of Ca2+ was observed, but loss of ΔΨm and cell viability 
were absent [45]. These findings indicated that loss in cell viability was 
determined by dissipation of ΔΨm. However, effects on ΔΨm were 
not readily observed in the absence of calcium, indicating that nsPEF-
induced dissipation of ΔΨm was calcium-dependent. Given that most, 
if not all, calcium-regulated responses are mediated by proteins, a 
possible explanation for this finding is that effects of nsPEFs may be 
on the mitochondria permeability transition pore, which is voltage- 
and calcium-dependent [61]. This suggestion requires additional 
experimentation. 
A Model And Overview Of Subcellular Targets And Cell 
Death Pathways Activated By nsPEFs In Vitro 
Figure 1 shows a scheme of our present understanding of possible 
subcellular targets and cell death mechanisms in response to nsPEFs, 
and summarizes the finding presented above. The model is mostly 
derived from experiments in human Jurkat cells. The dark green 
elements and arrows show primary pathways and subcellular effects, 
and the light green elements and arrows show secondary events that 
are involved, as cells die in response to nsPEFs. The muted elements 
do not appear to be operative in this model. Five possible primary 
targets were considered for nsPEF-induced cell death. These included 
aggregation of Fas receptors in plasma membranes [1], effects [2] 
on plasma membrane poration, on intracellular Ca2+ stores [3,4] on 
mitochondria, or on nuclei [5], and/or DNA. 
Mitochondria and plasma membranes are nsPEF targets
Based on the evidence presented above and elsewhere [44,45,55], 
mitochondria and the ΔΨm appear to be primary targets for nsPEFs; 
cell death was correlated with loss of ΔΨm. With one nsPEF waveform, 
cells responded with an influx of Ca2+, but without loss of ΔΨm and cell 
viability. However, dissipation of ΔΨm did not occur in the absence of 
calcium influx through plasma membranes. Thus, plasma membranes 
were also targets for nsPEFs. The presence of nanopores in the plasma 
membrane was observed when influx of Ca2+ could be seen at lower 
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Figure 1: A model of cell death targets and mechanisms of nsPEF-induced cell death in Jurkat cells. 
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electric fields than influx of propidium iodide [44]. These data fit the 
“two hit” hypothesis that requires a toxic stimulus, the nsPEF, as well as 
the presence of high Ca2+, as two requirements for opening the mPTP 
and disruption of ΔΨm [62,63]. Effects of nsPEFs on intracellular Ca2+ 
stores or on influx of Ca2+ alone were not sufficient for cell death in 
N1-S1 cells, because release of intracellular Ca2+ or Ca2+ influx without 
effects on ΔΨm did not lead to cell death [45]. 
Activation of the apoptosome
Thus, nsPEFs cause an influx of Ca2+, a decrease in ΔΨm, 
especially with fast rise-fall times, release of cytochrome c [51,55] and 
activation of caspase-9 and -3 [55]. This occurs through formation of 
the apoptosome, clearly indicating activation of well-characterized, 
intrinsic mitochondria-, APAF-1-mediated apoptosis pathway. In 
addition, at high electric fields, nsPEF induced caspase-independent 
cell death. Both caspase-dependent and –independent pathways most 
likely originate due to effects on mitochondria in cells exhibiting 
different fundamental cellular contexts. 
Bid cleavage
In these studies, caspases appear to cleave Bid, but this does not 
lead to cytochrome c release through the type II extrinsic pathway [55]. 
This must happen downstream of caspase-3 activation. The influx of 
Ca2+ most likely also leads to activation of calpain [54], which cleaves 
Bid, yet this does not seem to play a role in cytochrome c release 
because cytochrome c release is not affected by calpain inhibitors [45]. 
It is anticipated that the impact of nsPEFs on mitochondria is sufficient 
intense to exert maximum influence on cytochrome c release, leaving 
little of no effect on t-Bid on that event. 
DNA damage
Although DNA damage by double strand breaks was present in this 
Jurkat cell model as determined by Histone 2AX phosphorylation, its 
role in cell death has not yet been clearly determined. NsPEF-induced 
DNA damage has been demonstrated in a number of cell types by a 
number of assays in vitro [2,4,64,65], and in vivo [5,6]. In the Jurkat 
model here, the presence of DNA double strand breaks did not induce 
increases in Puma or Noxa, suggesting DNA damage was not a major 
mechanism to activate intrinsic apoptosis in response to nsPEF [45]. 
While such damage could lead to cell death, cell death has not been 
shown to be DNA damage-dependent. This is in contrast to cell death 
that has been shown to be dependent on Ca2+ -influx, on dissipation of 
ΔΨm, or on caspase activation shown here. 
The Fas receptor is not involved
Aggregation or other possible mechanisms for activating Fas 
receptors or the DISC do not appear to play a role in nsPEF-induced 
cell death; cytochrome c release was not affected by inhibition of 
caspases with z-VAD-fmk [55], which would be required if cell death 
signals were initiated through formation of the DISC. 
What causes the loss of ΔΨm?
Effects of nsPEFs have generally been considered to occur on 
membranes, so the most likely possibility for dissipation of ΔΨm is 
nanoporation of the inner mitochondria membrane, as suggested by 
the supra-electroporation theorem [47,48]. Nevertheless, poration 
of the plasma membrane is necessary, and the requirement for 
Ca2+ for dissipation of ΔΨm appears to come from the extracellular 
environment. However, poration is not expected to be Ca2+-dependent. 
Under these considerations, the most likely event is an effect of 
nsPEFs on a calcium- and/or voltage-dependent mechanism(s) of the 
mitochondria permeability transition pore (mPTP) [61]. The rationale 
for this conjecture is based on the requirement for Ca2+ for loss of 
ΔΨm, and the evidence that most if not all effects of Ca2+ are mediated 
through actions on proteins. The supposition of nsPEF effects on 
proteins is unexpected and requires further study. 
In Vivo Evidence For Mechanisms Of Cell Death And 
Successful Ablation Of Tumors With nsPEFs 
NsPEFs and cancer hallmarks
In tumor tissues, nsPEFs were first shown to reduce mouse B10.2 
squamous cell carcinoma tumor size and induce apoptosis as shown 
by TUNEL and activation of caspase catalytic activity [2,66]. They 
also have been shown to eliminate mouse ectopic B16f10 tumors [3-
5], ectopic mouse Hepa1-6 hepatocellular carcinoma [6], and murine 
xenographs of human pancreatic carcinoma [67]. It was of specific 
interest to determine mechanisms for tumor eradication based on rate 
limiting–stochastic events involved with cancer growth and treatment. 
A major complication in treating cancer is that it is really hundreds of 
different diseases; even melanoma or liver cancer is often not a single 
disease, not only among patients, but likely within the same patient. 
For example, the recurrence of a treated cancer is often a different 
cancer, even in the same organ [68]. Thus, cancers exhibit hundreds of 
different genotypes defined by substantial numbers of mutations in a 
wide variety of genes/proteins. In order to manage this array of diseases 
and to provide more focused characterization of cancer, Hanahan and 
Weinberg [69,70] defined eight major hallmarks of cancer that exhibit 
physiological anomalies that control cell homeostasis and proliferation. 
These include self-sufficiency in growth signals, insensitivity to 
growth-inhibitory (antigrowth) signals, evasion of apoptosis, limitless 
replicative potential, sustained angiogenesis, tissue invasion and 
metastasis, reprogramming energy metabolism and evasion of immune 
surveillance. In addition, genetic diversity of cancers is caused by an 
unstable genome. Further, inflammation advances multiple cancer 
hallmarks [70]. Considering these cancer hallmarks, it was relevant 
to determine which of them were altered by nsPEFs. In two different 
cancers, it has been shown that nsPEFs impinge upon multiple 
hallmarks, and can thereby, mimic several different specific treatments. 
For example, angiostatin and endostatin inhibit sustained angiogenesis; 
vinblastine and vincristine affect limitless replicative potential. 
Activation of caspase-associated and –unassociated cell death 
by nsPEFs
In both B16f10 [5] and Hepa1-6 tumors [6], nsPEFs were shown 
to induce apoptosis, as shown by activation of caspases, well-defined 
indicators of apoptosis. The time course for activation of caspases-2, -6 
and -7 mirrored cell shrinkage, decreases in nuclear size and nuclear 
condensation. These characteristics were paralleled by DNA damage, 
as indicated by TUNEL and histone 2AX phosphorylation; the latter is 
specific for DNA double strand breaks. The coincidence of these makers 
suggests that they were all part of the causes, and/or results of nsPEF 
effects on cancer cells. However, these studies also showed that not all 
cells exhibited active caspases after nsPEF treatment. This is consistent 
with the in vitro E4 SCC [54] and Jurkat cell [55] studies mentioned 
above, demonstrating both caspase-dependent and –independent cell 
death. 
Anti-angiogenesis/anti vascular effects with nsPEFs
Other evidence suggested that nsPEFs reversed sustained 
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angiogenesis [5,6]. First, there was a decrease in vessel numbers 
supplying tumors that was coincident with a decrease in tumor mass, 
indicating an interruption of tumor-driven angiogenesis and tumor 
blood supply. It could also be argued that there is an anti-vascular 
effect. This was also shown by Doppler analysis of blood flow in murine 
B16f10 melanoma [3]. Second, over a three week period after treatment 
of nsPEFs, vascular endothelial growth factor (VEGF) progressively 
decreased such that VEGF levels were one sixth the pre-treatment levels 
[5,6]. VEGF is a requirement for the angiogenic switch that defines 
homeostasis. This results in a loss of balance between stimulation and 
inhibition of new blood vessel growth. The angiogenic switch defines an 
early step for cancer metastasis and multistage carcinogenesis [69,70]. 
There were also decreases in platelet-derived endothelial cell growth 
factor, a well-known chemotactic factor for vascular endothelial cells 
and blood vessel formation. Moreover, effectors downstream of VEGF 
were decreased, including three major microvascular density markers: 
CD31, a platelet-endothelial cell adhesion molecule, used as a pan-
endothelial cell marker; CD34, an endothelial cell marker and CD105, 
a proliferation-related endothelial cell marker. Thus, while melanoma 
and hepatocellular carcinoma tumors shrank and vessel numbers 
were significantly reduced, formation of new vessels was extensively 
inhibited. 
NsPEFs and immune surveillance
In research that is ongoing and in need of further study, nsPEFs 
may reverse evasion of immune surveillance in nsPEF treated mouse 
ectopic Hepa1-6 HCC [71], and orthotopic N1-S1 HCC. In 6 of 8 
tumors that were cleared of Hepa1-6 HCC tumors for 60 days, none of 
the six grew new tumors for 49 days after being challenged with another 
tumor cell injection in the opposite flank. In contrast, all 8 age-matched 
naïve mice readily grew tumors. Similar results have also been observed 
in a UV-induced murine melanoma study [72]. After treatment with 
nsPEFs, challenge tumor cell injections resulted in slower growth of 
tumors cleared by nsPEFs than in mice treated by surgically removing 
tumors. This suggests that after treatment, the immune system might 
have alerted to recognize primary tumor cells as foreign. Thus, nsPEF 
treatment may induce immunogenic cell death, which has been shown 
to occur more readily when cells die in response to some, but not all 
apoptotic stimuli [73,74]. This suggests that successful treatment with 
nsPEFs may induce a vaccine response in the treated host that would 
prevent recurrence of tumors, which is a major problem in cancer 
therapy. 
Advantages of nsPEF Ablation For Cancer Treatment 
So what advantages do nsPEFs provide over other cancer 
treatments? First, nsPEFs target multiple cell death mechanisms. In 
in vitro experiments with B16f10 melanoma, E4 SSC and Jurkat cell 
models, as well as the ectopic models of melanoma and HCC, more than 
one mechanism for cell death was present. Second, nsPEFs produce a 
well-defined treatment zone, which is defined by a center active needle 
and four surrounding ground electrode in a 5 needle array [75]. When 
all tumor cells are placed within these treatment zone boundaries and 
are exposed to electric field strength, above an ablation threshold for a 
sufficient time, all tumor cells will die by more than one mechanism. 
Third, as shown in Jurkat cells and N1-S1 HCC models in vitro, nsPEF 
appears to target mitochondria, and the ΔΨm, especially when the 
plasma membrane is permeabilized and calcium is present. Fourth, 
nsPEFs can bypass cancer mutations when tumor cells are exposed 
to an ablation electric field for an appropriate period of time. Tumor 
cells that evade apoptosis by expressing mutation affecting the Fas and 
DISC pathways, or otherwise interfere with caspase activation will still 
die by caspase-independent mechanisms. Fifth, in addition to the anti-
angiogenesis effects of nsPEFs, they also have another advantage by 
local infarction of small vessels, as shown by the decrease in blood vessel 
numbers in the treatment zone [5]. Sixth, it can be argued that this 
treatment also has an anti-vascular effect within the treatment zone. A 
seventh advantage is the absence of local or systemic side effects by this 
treatment. While the treatment does involve delivery of electric fields, 
unpublished clinical trials indicated that injection of a local anesthetic, 
such as lidocaine, nullifies any pain. Eighth, since pulses are so short, 
there is for the most part, no muscle contraction as was shown when 
normal pig liver was treated with nsPEFs [75]. However, when treating 
ectopic tumors, it is important to prevent the electrode from coming 
intact with muscle or nerves leading to them, and to have the animal 
properly grounded during the treatment. Ninth, when electric fields 
are sufficiently intense, all cells in the treatment zone can be killed, 
including cancer stem cells and host cells that provide needed growth 
factors for tumor growth and metastasis. Finally, confirmation of the 
enhanced immune surveillance in humans after nsPEFs could provide 
a highly significant advantage to nsPEF treatment of tumors. 
Future Directions With nsPEF Treatment Of Cancer 
Pre-clinical studies indicate the feasibility and general safety for 
using nsPEF treatments for several types of cancer. While early studies 
were carried out with a mouse melanoma model [3,4,72], this is not the 
best disease model for clinical application for cancer treatment because 
melanoma is a systemic and metastatic disease, while nsPEF ablation is 
a localized treatment. More applicable cancers include squamous cell 
carcinoma [54,76] and basal cell carcinoma [7,77]. These are generally 
not metastatic, and are readily accessible and treatable malignancies 
for nsPEFs. 
We are presently finishing a series of studies using an orthotopic 
rat N1-S1 HCC model that shows excellent results. Our future goals 
are to treat larger HCC tumors with shorter treatment times. Also, we 
have specific interests in ongoing research in the orthotopic model for 
possible positive effects of nsPEFs, to enhance immune surveillance 
after treatment. We are in pursuit to identify mechanisms that are 
responsible for the absence of growth of a second challenge tumor 
cell injection, after successful nsPEF treatment of the primary tumor 
[71]. Other efforts are to develop applications of nsPEFs to include 
minimally invasive, laparoscopic treatments with catheter electrodes, 
guided by ultrasound using the rabbit VX2 HCC tumor model. 
Because cancers are always treated with more than one therapy, 
either in combination or in sequence, we have considered using low 
non-toxic doses of chemotherapeutic agents, before or after treatment 
with nsPEFs. We have recently demonstrated that nsPEFs and 
gemcitabine act synergistically to effectively treat an oral squamous cell 
carcinoma in vitro [78]. This would allow treatments of larger tumors 
with lower electric fields. 
We continue to be interested in mechanisms of nsPEF-induced 
cell death, and the N1-S1 tumor cells exhibits some behaviors that are 
different that previously observed. These tumor cells present a paradox. 
We see relative high caspase activity in untreated cells in vitro [79], 
that deceases with time and with increasing electric fields. However, in 
vivo, we see active caspase-3 in populations of cells in tissue slices from 
treated tumors. Nevertheless, as reported here and elsewhere [44,45], 
the nsPEF target is a calcium-dependent decrease in ΔΨm in these cells. 
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The State Of And The Future For Bioelectrics 
There are growing numbers of investigators in Bioelectric Centers 
around the World that are investigating all aspects of Bioelectrics, 
included at the beginning of this review. For example, the Frank Reidy 
Research Center for Bioelectrics at Old Dominion University now 
includes 17 principle investigators, occupying about 28,000 square 
feet in a new building that includes new state of the art animal facility 
and state of the art diagnostic and investigational equipment and 
instruments. There is now a Consortium for Bioelectrics, including 
3 Centers in the US, 2 in France, 2 in Germany, and 1 each in Italy, 
Slovenia and Japan. There are also other groups who are not part of 
the Consortium working on Bioelectrics in the US, Germany, France, 
Korea, Singapore, Japan and China. It is highly likely that the number 
of investigators will continue to grow, and new applications will be 
realized as Bioelectrics research continues to evolve.
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